New Results
In-Vivo Toxicity Studies and In-Vitro Inactivation of SARS-CoV-2 by Povidone-iodine In-situ Gel Forming Formulations
View ORCID ProfileBo Liang, View ORCID ProfileXudong Yuan, View ORCID ProfileGang Wei, Wei Wang, Ming Zhang, Haizhou Peng, Amin Javer, Michelle Mendenhall, Justin Julander, Sammi Huang, Hany Michail, Yong Lu, Qi Zhu, John Baldwin
doi: https://doi.org/10.1101/2020.05.18.103184
Bo Liang
1IView Therapeutics, Doylestown, PA 18902, USA (B. Liang, X. Yuan, W. Wang, M. Zhang, S. Huang, H. Michail, Q. Zhu, J. Baldwin)
3IVIEW Therapeutics (Zhuhai) Co. Ltd. Hengqin, Zhuhai, China (B. Liang, X. Yuan, W. Wang, H. Peng, Y. Lu, Q. Zhu)
Xudong Yuan
1IView Therapeutics, Doylestown, PA 18902, USA (B. Liang, X. Yuan, W. Wang, M. Zhang, S. Huang, H. Michail, Q. Zhu, J. Baldwin)
3IVIEW Therapeutics (Zhuhai) Co. Ltd. Hengqin, Zhuhai, China (B. Liang, X. Yuan, W. Wang, H. Peng, Y. Lu, Q. Zhu)
Gang Wei
2School of Pharmacy, Fudan University, Shanghai, China (G. Wei)
Wei Wang
1IView Therapeutics, Doylestown, PA 18902, USA (B. Liang, X. Yuan, W. Wang, M. Zhang, S. Huang, H. Michail, Q. Zhu, J. Baldwin)
3IVIEW Therapeutics (Zhuhai) Co. Ltd. Hengqin, Zhuhai, China (B. Liang, X. Yuan, W. Wang, H. Peng, Y. Lu, Q. Zhu)
Ming Zhang
1IView Therapeutics, Doylestown, PA 18902, USA (B. Liang, X. Yuan, W. Wang, M. Zhang, S. Huang, H. Michail, Q. Zhu, J. Baldwin)
Haizhou Peng
3IVIEW Therapeutics (Zhuhai) Co. Ltd. Hengqin, Zhuhai, China (B. Liang, X. Yuan, W. Wang, H. Peng, Y. Lu, Q. Zhu)
Amin Javer
4St. Paul’s Sinus Centre, University of British Columbia, Vancouver, Canada (A. Javer)
Michelle Mendenhall
5Institute for Antiviral Research, Utah State University, Logan, UT 84322, USA (M. Mendenhall, J. Julander)
Justin Julander
5Institute for Antiviral Research, Utah State University, Logan, UT 84322, USA (M. Mendenhall, J. Julander)
Sammi Huang
1IView Therapeutics, Doylestown, PA 18902, USA (B. Liang, X. Yuan, W. Wang, M. Zhang, S. Huang, H. Michail, Q. Zhu, J. Baldwin)
Hany Michail
1IView Therapeutics, Doylestown, PA 18902, USA (B. Liang, X. Yuan, W. Wang, M. Zhang, S. Huang, H. Michail, Q. Zhu, J. Baldwin)
Yong Lu
3IVIEW Therapeutics (Zhuhai) Co. Ltd. Hengqin, Zhuhai, China (B. Liang, X. Yuan, W. Wang, H. Peng, Y. Lu, Q. Zhu)
Qi Zhu
1IView Therapeutics, Doylestown, PA 18902, USA (B. Liang, X. Yuan, W. Wang, M. Zhang, S. Huang, H. Michail, Q. Zhu, J. Baldwin)
3IVIEW Therapeutics (Zhuhai) Co. Ltd. Hengqin, Zhuhai, China (B. Liang, X. Yuan, W. Wang, H. Peng, Y. Lu, Q. Zhu)
John Baldwin
1IView Therapeutics, Doylestown, PA 18902, USA (B. Liang, X. Yuan, W. Wang, M. Zhang, S. Huang, H. Michail, Q. Zhu, J. Baldwin)
Article usage
Posted May 20, 2020.
In-Vivo Toxicity Studies and In-Vitro Inactivation of SARS-CoV-2 by Povidone-iodine In-situ Gel Forming Formulations
Bo Liang, Xudong Yuan, Gang Wei, Wei Wang, Ming Zhang, Haizhou Peng, Amin Javer, Michelle Mendenhall, Justin Julander, Sammi Huang, Hany Michail, Yong Lu, Qi Zhu, John Baldwin
bioRxiv 2020.05.18.103184; doi: https://doi.org/10.1101/2020.05.18.103184
In-Vivo Toxicity Studies and In-Vitro Inactivation of SARS-CoV-2 by Povidone-iodine In-situ Gel Forming Formulations
Bo Liang, Xudong Yuan, Gang Wei, Wei Wang, Ming Zhang, Haizhou Peng, Amin Javer, Michelle Mendenhall, Justin Julander, Sammi Huang, Hany Michail, Yong Lu, Qi Zhu, John Baldwin
bioRxiv 2020.05.18.103184; doi: https://doi.org/10.1101/2020.05.18.103184
Subject Area
Subject Areas
- Biochemistry (11745)
- Bioengineering (8751)
- Bioinformatics (29195)
- Biophysics (14971)
- Cancer Biology (12095)
- Cell Biology (17411)
- Clinical Trials (138)
- Developmental Biology (9421)
- Ecology (14179)
- Epidemiology (2067)
- Evolutionary Biology (18306)
- Genetics (12245)
- Genomics (16802)
- Immunology (11867)
- Microbiology (28083)
- Molecular Biology (11592)
- Neuroscience (60965)
- Paleontology (451)
- Pathology (1870)
- Pharmacology and Toxicology (3238)
- Physiology (4959)
- Plant Biology (10427)
- Synthetic Biology (2885)
- Systems Biology (7339)
- Zoology (1651)